Revisions made in 2024 to the McDonald criteria allowed for the diagnosis of multiple sclerosis in a small cohort of ...
Concussion damage could linger in an athlete’s brain for at least a year, long after they’ve rejoined their sport, ...
A woman who was diagnosed with skin cancer which spread to her lymph nodes has said she is taking part in a clinical trial to ...
Among patients with multiple sclerosis, depression or anxiety are associated with being on Medicaid, clinical relapse, and DMT delay.
In this interview, Dr Tiffany Braley discusses the results of her latest study and best practices for personalized patient ...
Reports of anaphylaxis associated with the use of glatiramer acetate have prompted the Food and Drug Administration (FDA) to add a Boxed Warning to the prescribing information.
You disconnect your cell phone from its charger as you get ready for a busy day. But even though it has been connected all night, the battery is only partially charged. You look at ...
Endo, Inc. (OTCQX: NDOI) announced today that a post hoc data analysis of a Phase 3 clinical trial of XIAFLEX® (collagenase ...
Successful 2024 marked by significant clinical advancements across Oculis’ late-stage and highly differentiated clinical pipeline targeting retina (OCS-01 in diabetic macular edema), neuro-ophthalmic ...
Vitamin B6 deficiency may cause symptoms such as dermatitis and neuropathy in different parts of the body. Learn how to tell ...
4d
MedPage Today on MSNHigh-Dose Vitamin D Reduces Disease Activity in Early Multiple Sclerosis"It was important to conduct a large randomized controlled trial to evaluate the efficacy of high-dose cholecalciferol as ...
Tiziana is seeking FDA clearance for a Phase 2 clinical trial testing the safety and efficacy of its foralumab nasal spray in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results